A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆
Top Cited Papers
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 107 (2) , 177-185
- https://doi.org/10.1016/j.ygyno.2007.07.070
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterusGynecologic Oncology, 2004
- Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999Gynecologic Oncology, 2004
- Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcomeInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Adjuvant chemotherapy in early stage uterine sarcomas: an open question.2001
- A Multivariate Analysis of Clinicopathologic Factors for Predicting Outcome in Uterine SarcomasGynecologic Oncology, 1994
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Applications of crude incidence curvesStatistics in Medicine, 1992
- Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1986
- A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1985